Crizotiny
【Product name】XALKORI
[English common name]Crizotinib
[Chinese common name]Crizotiny
[English name]Crizotinib
[Chinese other name]Crizotinib
[Indications] XALKORI is a kinase inhibitor suitable for the treatment of the following patients:
(1) TransferNon-small cell lung cancer (NSCLC)Tumors were tested for anaplastic lymphoma kinase (ALK)-positive using an FDA-approved test.
(2) Metastatic NSCLC whose tumor is ROS1-positive.
【Dosage】
(1) Recommended dose: 250 mg orally, 2 times a day.
(2) Kidney damage: 250 mg orally, once a day in patients with severe renal impairment (creatinine clearance <30 mL / min) without dialysis.
[Storage]Pfizer Lab:20-25 ° C (may vary by 15-30 ° C).
[Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.